IGXT
Price:
$0.17
Market Cap:
$29.69M
IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also devel...[Read more]
Industry
Biotechnology
IPO Date
2007-01-17
Stock Exchange
PNK
Ticker
IGXT
According to IntelGenx Technologies Corp.’s latest financial reports and current stock price. The company's current ROE is 92.55%. This represents a change of 293.57% compared to the average of 23.51% of the last 4 quarters.
The mean historical ROE of IntelGenx Technologies Corp. over the last ten years is -321.45%. The current 92.55% ROE has changed -128.79% with respect to the historical average. Over the past ten years (40 quarters), IGXT's ROE was at its highest in in the September 2020 quarter at 1.91%. The ROE was at its lowest in in the December 2019 quarter at -908.19%.
Average
-321.45%
Median
-31.02%
Minimum
-4050.17%
Maximum
865.27%
Discovering the peaks and valleys of IntelGenx Technologies Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.90%
Maximum Annual ROE = 865.27%
Minimum Annual Increase = -245.33%
Minimum Annual ROE = -4050.17%
Year | ROE | Change |
---|---|---|
2023 | 81.06% | -76.81% |
2022 | 349.61% | -245.33% |
2021 | -240.56% | -127.80% |
2020 | 865.27% | -121.36% |
2019 | -4050.17% | 3.90% |
2018 | -101.21% | 27.02% |
2017 | -79.68% | 233.92% |
2016 | -23.86% | -202.84% |
2015 | 23.20% | -160.77% |
2014 | -38.18% | 16.66% |
The current ROE of IntelGenx Technologies Corp. (IGXT) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
63.37%
5-year avg
-598.96%
10-year avg
-321.45%
IntelGenx Technologies Corp.’s ROE is less than Adynxx, Inc. (0%), greater than NLS Pharmaceutics AG (0%), less than Ascletis Pharma Inc. (22.54%), greater than Sirona Biochem Corp. (-0.89%), less than LianBio (90.17%), less than Fennec Pharmaceuticals Inc. (0%), greater than Larimar Therapeutics, Inc. (-31.46%), greater than Verrica Pharmaceuticals Inc. (-52.10%), greater than Homology Medicines, Inc. (-35.87%), greater than Candel Therapeutics, Inc. (-691.62%), greater than PMV Pharmaceuticals, Inc. (-100.91%), greater than Acurx Pharmaceuticals, Inc. (-629.29%), greater than Monopar Therapeutics Inc. (-21.96%), greater than Enochian Biosciences, Inc. (-371.20%), greater than Connect Biopharma Holdings Limited (-110.60%), greater than Acumen Pharmaceuticals, Inc. (-47.54%), less than Eton Pharmaceuticals, Inc. (7.21%), greater than Nuvation Bio Inc. (-24.63%), greater than Eledon Pharmaceuticals, Inc. (-43.62%), greater than null (-98.79%), greater than null (-124.74%),
Company | ROE | Market cap |
---|---|---|
0% | $581.00 | |
0% | $7.33M | |
22.54% | $154.30M | |
-0.89% | $10.41M | |
90.17% | $34.47M | |
0% | $127.22M | |
-31.46% | $483.02M | |
-52.10% | $61.02M | |
-35.87% | $3.02M | |
-691.62% | $166.52M | |
-100.91% | $84.49M | |
-629.29% | $30.05M | |
-21.96% | $87.22M | |
-371.20% | $45.38M | |
-110.60% | $66.30M | |
-47.54% | $177.24M | |
7.21% | $215.73M | |
-24.63% | $764.36M | |
-43.62% | $280.20M | |
-98.79% | $0 | |
-124.74% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IntelGenx Technologies Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like IntelGenx Technologies Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is IntelGenx Technologies Corp.'s ROE?
How is the ROE calculated for IntelGenx Technologies Corp. (IGXT)?
What is the highest ROE for IntelGenx Technologies Corp. (IGXT)?
What is the 3-year average ROE for IntelGenx Technologies Corp. (IGXT)?
What is the 5-year average ROE for IntelGenx Technologies Corp. (IGXT)?
How does the current ROE for IntelGenx Technologies Corp. (IGXT) compare to its historical average?